Astrazeneca (AZN) Goodwill & Intangibles (2009 - 2026)

Astrazeneca's Goodwill & Intangibles history runs 18 years deep, the most recent figure standing at $58.1 billion for Q1 2026.

• In Q1 2026, Goodwill & Intangibles fell 0.99% year-over-year to $58.1 billion; the TTM figure through Mar 2026 stood at $58.1 billion (down 0.99% YoY), while the FY2025 annual figure was $59.1 billion, up 1.52% from the prior year.
• Goodwill & Intangibles was $58.1 billion for Q1 2026 at Astrazeneca, down from $59.1 billion in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $61.2 billion in Q1 2022 to a low of $2.4 billion in Q4 2023.
• Historically, Goodwill & Intangibles has averaged $55.8 billion across 5 years, with a median of $59.1 billion in 2022.
• The sharpest annual moves came in 2023 and 2024: Goodwill & Intangibles slumped 95.95% in 2023, then jumped 2331.16% in 2024.
• A 5-year view of Goodwill & Intangibles shows it stood at $59.1 billion in 2022, then plunged by 95.95% to $2.4 billion in 2023, then surged by 2331.16% to $58.2 billion in 2024, then grew by 1.52% to $59.1 billion in 2025, then fell by 1.67% to $58.1 billion in 2026.
• The last three Goodwill & Intangibles figures came in at $58.1 billion (Q1 2026), $59.1 billion (Q4 2025), and $59.4 billion (Q3 2025), per Business Quant data.